Effects of atorvastatin on warfarin-induced aortic medial calcification and systolic blood pressure in rats

Chengyun Liu , Jingjing Wan , Qunfang Yang , Benling Qi , Wen Peng , Xuelin Chen

Current Medical Science ›› 2008, Vol. 28 ›› Issue (10) : 535 -538.

PDF
Current Medical Science ›› 2008, Vol. 28 ›› Issue (10) : 535 -538. DOI: 10.1007/s11596-008-0510-1
Article

Effects of atorvastatin on warfarin-induced aortic medial calcification and systolic blood pressure in rats

Author information +
History +
PDF

Abstract

The effect of atorvastatin on warfarin-induced aortic medial calcification and systolic blood pressure (SBP) of rats induced by warfarin was studied. Thirty healthy and adult rats were randomly divided into Warfarin group (n=10), Atorvastatin group (n=10) and normal control group (n=10). Caudal arterial pressure of rats was measured once a week, and 4 weeks later, aorta was obtained. Elastic fiber, collagen fiber and calcium accumulation in tunica media of cells were measured by Von Kossa staining. The results showed that warfarin treatment led to elevation of systolic blood pressure and aortic medial calcification. The chronic treatment also increased collagen, but decreased elastin in the aorta. However, the atorvastatin treatment had adverse effects. It was concluded that treatment with atorvastatin presented evidence of blood pressure lowing and calcification reducing. These data demonstrate that atorvastatin protected aortic media from warfarin-induced calcification and elevation of systolic blood pressure.

Keywords

atorvastatin / systolic blood pressure / calcification/aortic

Cite this article

Download citation ▾
Chengyun Liu, Jingjing Wan, Qunfang Yang, Benling Qi, Wen Peng, Xuelin Chen. Effects of atorvastatin on warfarin-induced aortic medial calcification and systolic blood pressure in rats. Current Medical Science, 2008, 28(10): 535-538 DOI:10.1007/s11596-008-0510-1

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

CiuffettiG., SchillaciG., LombardiniR., et al.. Plasma viscosity in isolated systolic hypertension:the role of pulse pressure. Am J Hypertens, 2005, 18(7): 1005-1008

[2]

PaultreF., MoscaL.. Association of blood pressure indices and stroke mortality in isolated systolic hypertension. Stroke, 2005, 36: 1288-1290

[3]

MackeyR. H., VenkitachalamL., Sutton-TyrrellK., et al.. Calcifications, arterial stiffness and atherosclerosis. Adv Cardiol, 2007, 44: 234-244

[4]

EssalihiR., DaoH. H., YamaguchiN., et al.. A new model of isolated systolic hypertension induced by chronic warfarin and vitamin K1 treatment. Am J Hypertens, 2003, 16: 103-110

[5]

LaufsU., WassmannS., HilgersS., et al.. Rapid effects on vascular function after initiation and withdrawal of atorvastatin in healthy, normocholesterolemic men. Am J Cardiol, 2001, 88: 1306-1307

[6]

López-Cuenca A, Marín F, Roldán V et al. Effects of atorvastatin 80 mg daily on indices of matrix remodelling in ‘high-risk’ patients with ischemic heart disease. Int J Cradiol, 2008, epub.

[7]

MilionisH. J., LiberopoulosE. N., AchimastosA., et al.. Statins: another class of antihypertensive agents?. J Hum Hypertens, 2006, 20: 320-335

[8]

TsuangY., SunJ., ChenL., et al.. Direct effects of caffeine on osteoblastic cells metabolism: the possible causal effect of caffeine on the formation of osteoporosis. J Orthop Surg, 2006, 1: 7

[9]

FranklinS. S.. Hypertension in older people. J Clin Hypertens, 2006, 8(7): 521-525

[10]

GoodmanW. G., LondonG.. Vascular calcification in chronic kidney disease. Am J Kidney Dis, 2004, 43: 572-579

[11]

SaluskyI. B., GoodmanW. G.. Cardiovascular calcification in end-stage renal disease. Nephrol Dial Transplant, 2002, 17: 336-339

[12]

BudoffM. J., YuD., NasirK., et al.. Diabetes and progression of coronary calcium under the influence of statin therapy. Am Heart J, 2005, 149: 695-700

[13]

BlockG. A., SpiegelD. M., EhrlichJ., et al.. Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis. Kidney Int, 2005, 68: 1815-1824

[14]

DonnellC. J., SheaM. K., PriceP. A., et al.. Matrix Gla protein is associated with risk factors for atherosclerosis but not with coronary artery calcification. Arterioscler Thromb Vasc Biol, 2006, 26: 2769-2774

[15]

EssalihiR., DaoH. H., YamaguchiN., et al.. A new model of isolated systolic hypertension induced by chronic warfarin and vitamin K1 treatment. Am J Hypertension, 2003, 16: 103-110

[16]

SonB. K., KozakiK., IijimaK., et al.. Statins protect human aortic smooth muscle cells from inorganic phosphate-induced calcification by restoring Gas6-Axl survival pathway. Circ Res, 2006, 98: 1024-1031

[17]

SonB. K., KozakiK., IijimaK., et al.. Gas6/Axl-PI3K/Akt pathway plays a central role in the effect of statins on inorganic phosphate-induced calcification of vascular smooth muscle cells. Eur J Pharmacol, 2007, 556: 1-8

[18]

RajamannanN. M., SubramaniamM., StockS. R., et al.. Atorvastatin inhibits calcification and enhances nitric oxide synthase production in the hypercholesterolaemic aortic valve. Heart, 2005, 91: 806-810

[19]

KoosR., MahnkenA. H., MuhlenbruchG., et al.. Relation of oral anticoagulation to cardiac valvular and coronary calcium assessed by multislice spiral computed tomography. Am J Cardiol, 2005, 96: 747-749

[20]

StrazzulloP., KerryS. M., BarbatoA., et al.. Statins reduce blood pressure? A meta-analysis of randomized, controlled trials. Hypertension, 2007, 49: 792-798

AI Summary AI Mindmap
PDF

95

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/